Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men

Thrombosis and Haemostasis

Volumn 84, Issue 4, 2000, Pages 571-575

  Agewall, S ^a   Bokemark, L ^a   Wikstrand, J ^a   Lindahl, A ^a   Fagerberg, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Insulin sensitivity; Plasminogen activator inhibitor activity; Protein C; Protein S; Tissue plasminogen activator

Indexed keywords

ANTICOAGULANT PROTEIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0033786757     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614069     Document Type: Article

References (27)

1. Fibrinogen as a risk factor for stroke and myocardial infarction: The study of men born in 1913
2. Fibrinogen and risk of cardiovascular disease
3. Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
4. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease
5. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group
6. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
7. Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
8. Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease
9. D-dimers in relation to the severity of atherosclerosis in patients with stable angina pectoris after myocardial infarction
10. Coagulation and fibrinolytic factors in normotensive hypertension-prone men
11. Plasminogen activator inhibitor 1 activity is independent related to both insulin sensitivity and serum triglycerides in 70 year old men
12. Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk
13. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk
14. Body weight is more important than family history of hypertension for left ventricular function
15. The efficacy of multiple risk factor intervention in treated hypertensive men during long term follow-up
16. Glucose clamp technique: A method for quantifying insulin secretion and resistance
17. The euglycemic hyperinsulinemic clam examination: Variability and reproducibility
18. Dual-energy X-ray absorptiometry body composition model: Review of physical concepts
19. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease
20. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
21. Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes
22. Antithrombin III: Associations with age, sex, race, sex and cardiovascular disease risk factor
23. Relationship between maternal antithrombin III and protein C/proteins S levels before, during and after delivery
24. Reduced levels of coagulation inhibitors in chronic hemodilysis compared with CAPD
25. Constitutive synthesis of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor types 1 (PAI-1): Conditions and therapeutic targets
26. Fibrinogen, obesity and insulin resistance